Mylan Loses Bid to End States Generic Drug Price-Fixing Claims – Bloomberg Law News
Mylan Pharmaceuticals Inc. will have to face antitrust claims that it conspired with other drugmakers to inflate generic drug prices after a federal judge found sufficient evidence that the company participated in the conspiracy. Judge Michael P. Shea of the US District Court for the District of Co…
Source: Bloomberg Law News
Read More